{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T15:35:52Z","timestamp":1788104152977,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005367","name":"American Foundation for Surgery of the Hand","doi-asserted-by":"publisher","award":["3945"],"award-info":[{"award-number":["3945"]}],"id":[{"id":"10.13039\/100005367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jhsa.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:21:42Z","timestamp":1744644102000},"page":"93-102.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transforming Myofibroblasts Into Lipid-Filled Cells to Treat Dupuytren Disease"],"prefix":"10.1016","volume":"51","author":[{"given":"Mary E.","family":"Ziegler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Lem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyn","family":"Melkonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Nasrollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abtin","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Saina","family":"Saifzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalvin","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-8073","authenticated-orcid":false,"given":"Alan","family":"Widgerow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jhsa.2025.03.005_bib1","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target","volume":"110","author":"Verjee","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.005_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4055\/cios.2019.11.3.332","article-title":"Collagenase clostridium histolyticum injection for dupuytren contracture: 2-year follow-up","volume":"11","author":"Nayar","year":"2019","journal-title":"Clin Orthop Surg"},{"issue":"5","key":"10.1016\/j.jhsa.2025.03.005_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2106\/00004623-198163050-00014","article-title":"Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease","volume":"63","author":"Brickley-Parsons","year":"1981","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.005_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031430","article-title":"In vitro study of novel collagenase (XIAFLEX(R)) on Dupuytren's disease fibroblasts displays unique drug related properties","volume":"7","author":"Syed","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.005_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13287-016-0356-6","article-title":"Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38\/MAPK signaling pathway","volume":"7","author":"Li","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.005_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/PRS.0000000000000504","article-title":"Adipose tissue-derived stromal cells inhibit TGF-beta1-induced differentiation of human dermal fibroblasts and keloid scar-derived fibroblasts in a paracrine fashion","volume":"134","author":"Spiekman","year":"2014","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.jhsa.2025.03.005_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.stem.2020.03.013","article-title":"Dermal adipocyte lipolysis and myofibroblast conversion are required for efficient skin repair","volume":"26","author":"Shook","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.005_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15054","article-title":"Tissue fibrosis associated depletion of lipid-filled cells","volume":"33","author":"Jussila","year":"2024","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.005_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4252\/wjsc.v14.i2.200","article-title":"Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars","volume":"14","author":"Vanderstichele","year":"2022","journal-title":"World J Stem Cells"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.005_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tibtech.2006.01.010","article-title":"Fat tissue: an underappreciated source of stem cells for biotechnology","volume":"24","author":"Fraser","year":"2006","journal-title":"Trends Biotechnol"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.005_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.08.014","article-title":"The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors","volume":"375","author":"Kalen","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhsa.2025.03.005_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7183734","article-title":"Allogeneic platelet releasate preparations derived via a novel rapid thrombin activation process promote rapid growth and increased BMP-2 and BMP-4 expression in human adipose-derived stem cells","volume":"2016","author":"McLaughlin","year":"2016","journal-title":"Stem Cells Int"},{"issue":"9","key":"10.1016\/j.jhsa.2025.03.005_bib13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhsa.2023.06.007","article-title":"Targeting myofibroblasts as a treatment modality for dupuytren disease","volume":"48","author":"Ziegler","year":"2023","journal-title":"J Hand Surg Am"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.005_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.stem.2016.10.004","article-title":"Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis","volume":"20","author":"El Agha","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"6326","key":"10.1016\/j.jhsa.2025.03.005_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1126\/science.aai8792","article-title":"Regeneration of fat cells from myofibroblasts during wound healing","volume":"355","author":"Plikus","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.005_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250007","article-title":"Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: a systematic review of Level I and II studies","volume":"16","author":"Nazaroff","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.005_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jcmm.12425","article-title":"Implications for human adipose-derived stem cells in plastic surgery","volume":"19","author":"Banyard","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jhsa.2025.03.005_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12891-015-0597-z","article-title":"Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat","volume":"16","author":"Satish","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"10.1016\/j.jhsa.2025.03.005_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/ar4070","article-title":"The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy","volume":"14","author":"Fang","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"24","key":"10.1016\/j.jhsa.2025.03.005_bib20","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13523","article-title":"Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice","volume":"5","author":"Jenke","year":"2017","journal-title":"Physiol Rep"},{"issue":"8","key":"10.1016\/j.jhsa.2025.03.005_bib21","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/stem.2052","article-title":"IGF1 Promotes adipogenesis by a lineage bias of endogenous adipose stem\/progenitor cells","volume":"33","author":"Hu","year":"2015","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.jhsa.2025.03.005_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1152\/japplphysiol.00503.2012","article-title":"Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling","volume":"114","author":"Pansters","year":"2013","journal-title":"J Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.005_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/jsre.1997.5080","article-title":"EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells","volume":"69","author":"Qureshi","year":"1997","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.005_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/path.2483","article-title":"An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease","volume":"217","author":"Pavelic","year":"2009","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.005_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13287-020-01895-1","article-title":"Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury","volume":"11","author":"Hu","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.jhsa.2025.03.005_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00535-019-01599-1","article-title":"The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease","volume":"54","author":"Driscoll","year":"2019","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.005_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13287-019-1289-7","article-title":"Harnessing the secretome of adipose-derived stem cells in the treatment of ischemic heart diseases","volume":"10","author":"Li","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jhsa.2025.03.005_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.669037","article-title":"Adipose stromal cell-secretome counteracts profibrotic signals from IPF lung matrices","volume":"12","author":"Vasse","year":"2021","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.jhsa.2025.03.005_bib29","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/jcm8111979","article-title":"Adipose-derived stem cells from systemic sclerosis patients maintain pro-angiogenic and antifibrotic paracrine effects in vitro","volume":"8","author":"Velier","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhsa.2025.03.005_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:28:07Z","timestamp":1778689687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502325001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0363502325001327"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.03.005","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming Myofibroblasts Into Lipid-Filled Cells to Treat Dupuytren Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Society for Surgery of the Hand. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}